How sloppy analysis is hiding the truth about a crucial aging gene
Researchers found that conflicting results about APOE—a gene strongly linked to aging, disease, and lifespan—stem not from biology but from inconsistent analytical choices across studies. The discovery signals a broader reproducibility crisis in genetic epidemiology that could undermine confidence in gene-based drug targets and clinical predictions.
Originaltitel: Modeling APOE, morbidity, and mortality: a reproducibility challenge for genetic epidemiology
APOE is among the most extensively studied genetic loci in research on aging, morbidity, and mortality. Despite its well-established biological roles, empirical findings on the association between APOE and mortality remain inconsistent across studies. This heterogeneity is often attributed to biological complexity. In this Perspective, we argue that much of the apparent inconsistency instead reflects differences in modeling choices, variable definitions, and reporting practices, resulting in limited reproducibility and comparability. We highlight how pleiotropy, age-dependent effects, and selective survival make APOE particularly sensitive to analytical decisions. We focus on three underappreciated sources of irreproducibility: selective exclusion of rare APOE genotypes, lack of standardized baseline models, and routine adjustment for variables that are not confounders under Mendelian inheritance. We argue that all observed APOE genotypes should be included in primary analyses, that parsimonious baseline models adjusted only for variables independent of genotype should always be reported, and that overadjustment can obscure rather than clarify genetic effects. We propose a set of conceptual principles to improve reproducibility in studies of APOE , morbidity, and mortality, with implications for genetic epidemiology more broadly.